Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $BDSX vs $VMD | Chartloom

Compare

$BDSX vs $VMD

Biodesix Inc · Viemed Healthcare Inc

BDSX

Biodesix Inc

VMD

Viemed Healthcare Inc

Compare $BDSX vs $VMD

Comparing Biodesix Inc and Viemed Healthcare Inc

BDSXBiodesix Inc

VMDViemed Healthcare Inc

BDSXBiodesix Inc

Market cap

$249M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.00x

Rev growth (TTM)

34.5%

YTD performance

271.4%

52W performance

224.2%

FCF yield

-8.2%

VMDViemed Healthcare Inc

Market cap

$372M

P/E (TTM)

27.49x

Forward P/E (NTM)

19.32x

Forward P/S (NTM)

1.10x

Rev growth (TTM)

25.2%

YTD performance

34.2%

52W performance

40.8%

FCF yield

7.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BDSX

VMD

Detailed metrics comparison

BDSX

Biodesix Inc

VMD

Viemed Healthcare Inc

Market Cap

BDSX$249M

VMD$372M

Enterprise Value

BDSX$265M

VMD$368M

Price

BDSX$23.99

VMD$9.69

P/E Ratio

BDSXN/A

VMD27.49x

P/S Ratio

BDSX2.41x

VMD1.23x

EV/Sales

BDSX2.58x

VMD1.22x

EV/EBITDA

BDSX0.00x

VMD6.66x

P/B Ratio

BDSX30.02x

VMD2.52x

P/FCF Ratio

BDSXN/A

VMD12.71x

EV/FCF

BDSX-13.01x

VMD12.58x

PEG Ratio

BDSXN/A

VMD1.16x

Forward P/E (NTM)

BDSXN/A

VMD19.32x

Forward P/S (NTM)

BDSX2.00x

VMD1.10x

Revenue (TTM)

BDSX$103M

VMD$302M

Revenue Growth (YoY)

BDSX34.5%

VMD25.2%

Forward Rev Growth

BDSX20.2%

VMD11.2%

Gross Margin (TTM)

BDSX82.5%

VMD57.5%

Operating Margin (TTM)

BDSX0.0%

VMD7.5%

EBITDA Margin (TTM)

BDSX-14.6%

VMD18.1%

Net Margin (TTM)

BDSX-27.0%

VMD4.8%

FCF Margin (TTM)

BDSX-19.8%

VMD9.7%

Net Income (TTM)

BDSX$-28M

VMD$14M

FCF (TTM)

BDSX$-20M

VMD$29M

EPS (TTM)

BDSX-$2.70

VMD$0.35

ROE (TTM)

BDSX-16487.0%

VMD10.3%

ROA (TTM)

BDSX-3033.0%

VMD7.2%

ROIC (TTM)

BDSX-2700.0%

VMD9.5%

Cash

BDSX$30M

VMD$11M

Debt

BDSX$47M

VMD$7M

Net Cash/Debt

BDSX$-17M

VMD$4M

Current Ratio (TTM)

BDSX2.85x

VMD1.13x

Quick Ratio (TTM)

BDSX2.85x

VMD0.90x

Debt/Equity (TTM)

BDSX5.12x

VMD0.05x

Debt/Assets (TTM)

BDSX0.0%

VMD0.0%

Interest Coverage (TTM)

BDSXN/A

VMDN/A

Net Debt/EBITDA (TTM)

BDSX0.00x

VMD0.00x

Beta

BDSX0.60

VMD1.05

52W Performance

BDSX224.2%

VMD40.8%

YTD Performance

BDSX271.4%

VMD34.2%

% from 52W High

BDSX-25.0%

VMD-23.2%

% from 52W Low

BDSX356.1%

VMD60.2%

Asset Turnover (TTM)

BDSX1.12x

VMD1.50x

FCF Yield (TTM)

BDSX-8.2%

VMD7.9%

Earnings Yield (TTM)

BDSX-11.2%

VMD3.9%

Dividend Yield (TTM)

BDSXN/A

VMDN/A

Rule of 40

BDSX14.6

VMD34.9

EV/GP/RG

BDSX0.15

VMD0.18

Ticker research

View BDSX research View VMD research

Metric	BDSX Biodesix Inc	VMD Viemed Healthcare Inc
Market & Valuation
Market Cap	$249M	$372M
Enterprise Value	$265M	$368M
Price	$23.99	$9.69
P/E Ratio	N/A	27.49x
P/S Ratio	2.41x	1.23x
EV/Sales	2.58x	1.22x
EV/EBITDA	0.00x	6.66x
P/B Ratio	30.02x	2.52x
P/FCF Ratio	N/A	12.71x
EV/FCF	-13.01x	12.58x
PEG Ratio	N/A	1.16x
Forward P/E (NTM)	N/A	19.32x
Forward P/S (NTM)	2.00x	1.10x
Revenue & Growth
Revenue (TTM)	$103M	$302M
Revenue Growth (YoY)	34.5%	25.2%
Forward Rev Growth	20.2%	11.2%
Profitability
Gross Margin (TTM)	82.5%	57.5%
Operating Margin (TTM)	0.0%	7.5%
EBITDA Margin (TTM)	-14.6%	18.1%
Net Margin (TTM)	-27.0%	4.8%
FCF Margin (TTM)	-19.8%	9.7%
Net Income (TTM)	$-28M	$14M
FCF (TTM)	$-20M	$29M
EPS (TTM)	-$2.70	$0.35
ROE (TTM)	-16487.0%	10.3%
ROA (TTM)	-3033.0%	7.2%
ROIC (TTM)	-2700.0%	9.5%
Financial Health
Cash	$30M	$11M
Debt	$47M	$7M
Net Cash/Debt	$-17M	$4M
Current Ratio (TTM)	2.85x	1.13x
Quick Ratio (TTM)	2.85x	0.90x
Debt/Equity (TTM)	5.12x	0.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	1.05
52W Performance	224.2%	40.8%
YTD Performance	271.4%	34.2%
% from 52W High	-25.0%	-23.2%
% from 52W Low	356.1%	60.2%
Efficiency & Yields
Asset Turnover (TTM)	1.12x	1.50x
FCF Yield (TTM)	-8.2%	7.9%
Earnings Yield (TTM)	-11.2%	3.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	14.6	34.9
EV/GP/RG	0.15	0.18
Ticker research	View BDSX research	View VMD research

Valuation

P/E Ratio

VMD

27.49x

P/S Ratio

VMD

1.23x

BDSX

2.41x

EV/FCF

BDSX

-13.01x

VMD

12.58x

Growth & revenue

Revenue Growth TTM

BDSX

34.5%

VMD

25.2%

Forward Revenue Growth

BDSX

20.2%

VMD

11.2%

Profitability & performance

Gross Margin

BDSX

82.5%

VMD

57.5%

ROE

VMD

10.3%

BDSX

-16487.0%

FCF Yield %

VMD

7.9%

BDSX

-8.2%

52-Week Performance

BDSX

224.2%

VMD

40.8%

Detailed metrics comparison

BDSX

Biodesix Inc

VMD

Viemed Healthcare Inc

Market Cap

BDSX$249M

VMD$372M

Enterprise Value

BDSX$265M

VMD$368M

Price

BDSX$23.99

VMD$9.69

P/E Ratio

BDSXN/A

VMD27.49x

P/S Ratio

BDSX2.41x

VMD1.23x

EV/Sales

BDSX2.58x

VMD1.22x

EV/EBITDA

BDSX0.00x

VMD6.66x

P/B Ratio

BDSX30.02x

VMD2.52x

P/FCF Ratio

BDSXN/A

VMD12.71x

EV/FCF

BDSX-13.01x

VMD12.58x

PEG Ratio

BDSXN/A

VMD1.16x

Forward P/E (NTM)

BDSXN/A

VMD19.32x

Forward P/S (NTM)

BDSX2.00x

VMD1.10x

Revenue (TTM)

BDSX$103M

VMD$302M

Revenue Growth (YoY)

BDSX34.5%

VMD25.2%

Forward Rev Growth

BDSX20.2%

VMD11.2%

Gross Margin (TTM)

BDSX82.5%

VMD57.5%

Operating Margin (TTM)

BDSX0.0%

VMD7.5%

EBITDA Margin (TTM)

BDSX-14.6%

VMD18.1%

Net Margin (TTM)

BDSX-27.0%

VMD4.8%

FCF Margin (TTM)

BDSX-19.8%

VMD9.7%

Net Income (TTM)

BDSX$-28M

VMD$14M

FCF (TTM)

BDSX$-20M

VMD$29M

EPS (TTM)

BDSX-$2.70

VMD$0.35

ROE (TTM)

BDSX-16487.0%

VMD10.3%

ROA (TTM)

BDSX-3033.0%

VMD7.2%

ROIC (TTM)

BDSX-2700.0%

VMD9.5%

Cash

BDSX$30M

VMD$11M

Debt

BDSX$47M

VMD$7M

Net Cash/Debt

BDSX$-17M

VMD$4M

Current Ratio (TTM)

BDSX2.85x

VMD1.13x

Quick Ratio (TTM)

BDSX2.85x

VMD0.90x

Debt/Equity (TTM)

BDSX5.12x

VMD0.05x

Debt/Assets (TTM)

BDSX0.0%

VMD0.0%

Interest Coverage (TTM)

BDSXN/A

VMDN/A

Net Debt/EBITDA (TTM)

BDSX0.00x

VMD0.00x

Beta

BDSX0.60

VMD1.05

52W Performance

BDSX224.2%

VMD40.8%

YTD Performance

BDSX271.4%

VMD34.2%

% from 52W High

BDSX-25.0%

VMD-23.2%

% from 52W Low

BDSX356.1%

VMD60.2%

Asset Turnover (TTM)

BDSX1.12x

VMD1.50x

FCF Yield (TTM)

BDSX-8.2%

VMD7.9%

Earnings Yield (TTM)

BDSX-11.2%

VMD3.9%

Dividend Yield (TTM)

BDSXN/A

VMDN/A

Rule of 40

BDSX14.6

VMD34.9

EV/GP/RG

BDSX0.15

VMD0.18

Ticker research

View BDSX research View VMD research

Metric	BDSX Biodesix Inc	VMD Viemed Healthcare Inc
Market & Valuation
Market Cap	$249M	$372M
Enterprise Value	$265M	$368M
Price	$23.99	$9.69
P/E Ratio	N/A	27.49x
P/S Ratio	2.41x	1.23x
EV/Sales	2.58x	1.22x
EV/EBITDA	0.00x	6.66x
P/B Ratio	30.02x	2.52x
P/FCF Ratio	N/A	12.71x
EV/FCF	-13.01x	12.58x
PEG Ratio	N/A	1.16x
Forward P/E (NTM)	N/A	19.32x
Forward P/S (NTM)	2.00x	1.10x
Revenue & Growth
Revenue (TTM)	$103M	$302M
Revenue Growth (YoY)	34.5%	25.2%
Forward Rev Growth	20.2%	11.2%
Profitability
Gross Margin (TTM)	82.5%	57.5%
Operating Margin (TTM)	0.0%	7.5%
EBITDA Margin (TTM)	-14.6%	18.1%
Net Margin (TTM)	-27.0%	4.8%
FCF Margin (TTM)	-19.8%	9.7%
Net Income (TTM)	$-28M	$14M
FCF (TTM)	$-20M	$29M
EPS (TTM)	-$2.70	$0.35
ROE (TTM)	-16487.0%	10.3%
ROA (TTM)	-3033.0%	7.2%
ROIC (TTM)	-2700.0%	9.5%
Financial Health
Cash	$30M	$11M
Debt	$47M	$7M
Net Cash/Debt	$-17M	$4M
Current Ratio (TTM)	2.85x	1.13x
Quick Ratio (TTM)	2.85x	0.90x
Debt/Equity (TTM)	5.12x	0.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	1.05
52W Performance	224.2%	40.8%
YTD Performance	271.4%	34.2%
% from 52W High	-25.0%	-23.2%
% from 52W Low	356.1%	60.2%
Efficiency & Yields
Asset Turnover (TTM)	1.12x	1.50x
FCF Yield (TTM)	-8.2%	7.9%
Earnings Yield (TTM)	-11.2%	3.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	14.6	34.9
EV/GP/RG	0.15	0.18
Ticker research	View BDSX research	View VMD research